Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

      EHA Delphine Rea


    Dr Delphine Rea
    Département Médico-Universitaire d’Hématologie et Immunologie
    Hôpital Saint-Louis,
    Paris (France)

    Flagge Frankreich
    Update on CML and COVID-19 management - in French

    • COVID-19 in patients with CML: case reports
    • COVID-19 in CML: The iCMLf CANDID study
    • May ABL kinase inhibitors against CML help fighting COVID-19?
    • Imatinib treatment for COVID-19: A case report
    • Managing CML patients during the COVID-19 pandemic: an ESMO-ESH interdisciplinary expert consensus
    • Immune responses in 16 CML patients after one injection of the SARS-CoV-2 BNT162b2 vaccine
    • Humoral responses in 62 CML patients after 2 injections of anti-SARS CoV-2 vaccines
    • Conclusion